Objectives: Prognostic assessment in metastatic gastric cancer remains challenging because survival is influenced by both tumor biology and host-related clinical condition. This study evaluated the prognostic value of baseline prognostic nutritional index (PNI), early CA19-9 dynamics, and a simple composite score for overall survival stratification. Methods: This retrospective cohort study included patients with histologically confirmed metastatic gastric adenocarcinoma treated at a single tertiary oncology center. Baseline clinicopathological, laboratory, treatment, and survival data were collected from institutional records. PNI was calculated from serum albumin and peripheral lymphocyte count. Early CA19-9 change was defined as the percentage change between baseline and early follow-up values. Landmark- restricted analyses were used for tumor marker kinetics. A composite score was constructed using two adverse factors: low baseline PNI and insufficient CA19-9 decline. Overall survival was analyzed using Kaplan–Meier and Cox regression models. Results: Among 126 patients, 95 had available data for both baseline PNI and early CA19-9 kinetics. High-risk patients had shorter median overall survival than low/intermediate-risk patients: 8 versus 14 months, respectively (log-rank p=0.028). In multivariable analysis, a high composite score remained independently associated with inferior overall survival (adjusted HR: 3.05, 95% CI: 1.66–5.62; p<0.001). Conclusion: A composite score integrating baseline PNI and early CA19-9 dynamics may provide clinically useful survival stratification in metastatic gastric cancer. Keywords: CA19-9, composite prognostic score, metastatic gastric cancer; overall survival, prognostic nutritional index, tumor marker kinetics
Corresponding Author: Tuba Baydaş